Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivmecillinam prophylaxis for infections after kidney transplantation in recipients with early bacteriuria
NCT07407673Phase 3Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jul 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pivmecillinam in urinary tract infection (UTI), bloodstream infection (BSI). Planned start Jan 2027; status: not yet recruiting.
02
Drugs
pivmecillinam
03
Conditions
urinary tract infection (UTI)bloodstream infection (BSI)
Beyond the preview
Go deeper on NCT07407673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07407673.